Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Apr 22, 2024
Document Date
Apr 10, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
DUBE MICHAEL P